Pathological complete response rate to anthracycline versus nonanthracycline based chemotherapy regimens in localized and regional HER2 neu positive breast cancer.doi:10.1200/JCO.2024.42.16_suppl.e126324e12632#Background:Debate over the need of anthracycline as part of neoadjuvant chemotherapy in HER2-neu...
aToday, it's the local humans whose numbers are under threat. 今天,它是数字在威胁外的地方人。[translate] aAssignments 任务[translate] aPathological complete response in younger and older breast cancer patients. 病理性完全反应在更加年轻和更老的乳腺癌患者。[translate]...
This exploratory analysis of the Neoadjuvant Carboplatin in Triple Negative Breast Cancer (NACATRINE) study aimed to identify the biomarkers of pathological complete response (pCR) in patients with triple-negative breast cancer (TNBC) treated with neoadj
Oncology Nomogram for prediction of pathological complete response in human epidermal growth factor 2 (HER22) receptor positive breast cancer patients treated with neoadjuvant systemic therapy THE UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH Jose-Miguel Yamal Fujii...
are more prevalent in TNBC compared to other breast cancer subtypes12. sTILs have been shown to provide robust prognostic value in early and loco-regionally advanced TNBC, both in patients with and without (neo) adjuvant chemotherapy, and strongly correlate with pathological complete response (pCR)...
Merck announces phase 3 KEYNOTE-756 trial met primary endpoint of pathological complete response (pCR) rate in patients with high-risk, early-stage ER+/HER2-breast cancer. Merck. News release. July 28, 2023. Accessed July 28, 2023. https://www.merck.com/news/mer...
Although the effectiveness of perioperative adjuvant therapy in the treatment of hepatocellular carcinoma (HCC) has been investigated, the efficacy of preoperative therapy is unclear. Herein, we report a case of pathological complete response after percu
(2012) The discrepancy between high pathological complete response (pCR) rate and low breast conserving surgery (BCS) following neoadjuvant therapy: analysis ... C Criscitiello,HA Azim,D Agbor-Tarh,... - Congress of the European-society-for-medical-oncology 被引量: 2发表: 2012年 Radiation ...
Complete pathological response occurs in 10–20% of patients with rectal cancer who are treated with neoadjuvant chemoradiation therapy prior to pelvic surgery. The possibility that complete pathological response of rectal cancer can also occur with neoa
Accurate prediction of pathological complete response (pCR) to NAC in the early-stage or posttreatment can optimize treatment strategies or improve the breast-conserving rate. This study aimed to develop and validate an autosegmentation-based serial ultrasonography assessment system (SUAS) that ...